Routine surveillance for symptomatic toxicities with real-time clinician reporting in Danish breast cancer patients—Organization and design of the first national, cluster randomized trial using the Patient-Reported Outcomes version of Common Terminology Criteria for Adverse Events (PRO-CTCAE)

Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › fagfællebedømt

Standard

Routine surveillance for symptomatic toxicities with real-time clinician reporting in Danish breast cancer patients—Organization and design of the first national, cluster randomized trial using the Patient-Reported Outcomes version of Common Terminology Criteria for Adverse Events (PRO-CTCAE). / Pappot, Helle; Bæksted, Christina; Knoop, Ann; Mitchell, Sandra A.; Nissen, Aase; Johansen, Christoffer.

I: Breast Journal, Bind 25, Nr. 2, 2019, s. 269-272.

Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › fagfællebedømt

Harvard

Pappot, H, Bæksted, C, Knoop, A, Mitchell, SA, Nissen, A & Johansen, C 2019, 'Routine surveillance for symptomatic toxicities with real-time clinician reporting in Danish breast cancer patients—Organization and design of the first national, cluster randomized trial using the Patient-Reported Outcomes version of Common Terminology Criteria for Adverse Events (PRO-CTCAE)', Breast Journal, bind 25, nr. 2, s. 269-272. https://doi.org/10.1111/tbj.13204

APA

Pappot, H., Bæksted, C., Knoop, A., Mitchell, S. A., Nissen, A., & Johansen, C. (2019). Routine surveillance for symptomatic toxicities with real-time clinician reporting in Danish breast cancer patients—Organization and design of the first national, cluster randomized trial using the Patient-Reported Outcomes version of Common Terminology Criteria for Adverse Events (PRO-CTCAE). Breast Journal, 25(2), 269-272. https://doi.org/10.1111/tbj.13204

Vancouver

Pappot H, Bæksted C, Knoop A, Mitchell SA, Nissen A, Johansen C. Routine surveillance for symptomatic toxicities with real-time clinician reporting in Danish breast cancer patients—Organization and design of the first national, cluster randomized trial using the Patient-Reported Outcomes version of Common Terminology Criteria for Adverse Events (PRO-CTCAE). Breast Journal. 2019;25(2):269-272. https://doi.org/10.1111/tbj.13204

Author

Pappot, Helle ; Bæksted, Christina ; Knoop, Ann ; Mitchell, Sandra A. ; Nissen, Aase ; Johansen, Christoffer. / Routine surveillance for symptomatic toxicities with real-time clinician reporting in Danish breast cancer patients—Organization and design of the first national, cluster randomized trial using the Patient-Reported Outcomes version of Common Terminology Criteria for Adverse Events (PRO-CTCAE). I: Breast Journal. 2019 ; Bind 25, Nr. 2. s. 269-272.

Bibtex

@article{b95a46cadbcd49b6a185be1c947ddafe,
title = "Routine surveillance for symptomatic toxicities with real-time clinician reporting in Danish breast cancer patients—Organization and design of the first national, cluster randomized trial using the Patient-Reported Outcomes version of Common Terminology Criteria for Adverse Events (PRO-CTCAE)",
abstract = "The Patient-Reported Outcomes version of Common Terminology Criteria for Adverse Events (PRO-CTCAE) was developed by the National Cancer Institute to capture patient self-reports of symptomatic toxicities during cancer treatment. The aim of this short communication is to describe the design of a national study, which examine the effect of using patients{\textquoteright} electronic PRO-CTCAE reporting with real-time feedback to clinicians on treatment events for breast cancer patients receiving adjuvant chemotherapy. The study's end-points are defined as dose reduction, hospitalization, and febrile neutropenia. This is the first report on the impact of PRO-CTCAE in a national breast cancer population during chemotherapy treatment.",
keywords = "adjuvant chemotherapy, breast cancer, patient reported outcome, PRO-CTCAE, toxicity",
author = "Helle Pappot and Christina B{\ae}ksted and Ann Knoop and Mitchell, {Sandra A.} and Aase Nissen and Christoffer Johansen",
year = "2019",
doi = "10.1111/tbj.13204",
language = "English",
volume = "25",
pages = "269--272",
journal = "Breast Journal",
issn = "1075-122X",
publisher = "Wiley-Blackwell",
number = "2",

}

RIS

TY - JOUR

T1 - Routine surveillance for symptomatic toxicities with real-time clinician reporting in Danish breast cancer patients—Organization and design of the first national, cluster randomized trial using the Patient-Reported Outcomes version of Common Terminology Criteria for Adverse Events (PRO-CTCAE)

AU - Pappot, Helle

AU - Bæksted, Christina

AU - Knoop, Ann

AU - Mitchell, Sandra A.

AU - Nissen, Aase

AU - Johansen, Christoffer

PY - 2019

Y1 - 2019

N2 - The Patient-Reported Outcomes version of Common Terminology Criteria for Adverse Events (PRO-CTCAE) was developed by the National Cancer Institute to capture patient self-reports of symptomatic toxicities during cancer treatment. The aim of this short communication is to describe the design of a national study, which examine the effect of using patients’ electronic PRO-CTCAE reporting with real-time feedback to clinicians on treatment events for breast cancer patients receiving adjuvant chemotherapy. The study's end-points are defined as dose reduction, hospitalization, and febrile neutropenia. This is the first report on the impact of PRO-CTCAE in a national breast cancer population during chemotherapy treatment.

AB - The Patient-Reported Outcomes version of Common Terminology Criteria for Adverse Events (PRO-CTCAE) was developed by the National Cancer Institute to capture patient self-reports of symptomatic toxicities during cancer treatment. The aim of this short communication is to describe the design of a national study, which examine the effect of using patients’ electronic PRO-CTCAE reporting with real-time feedback to clinicians on treatment events for breast cancer patients receiving adjuvant chemotherapy. The study's end-points are defined as dose reduction, hospitalization, and febrile neutropenia. This is the first report on the impact of PRO-CTCAE in a national breast cancer population during chemotherapy treatment.

KW - adjuvant chemotherapy

KW - breast cancer

KW - patient reported outcome

KW - PRO-CTCAE

KW - toxicity

U2 - 10.1111/tbj.13204

DO - 10.1111/tbj.13204

M3 - Journal article

C2 - 30761667

AN - SCOPUS:85061456159

VL - 25

SP - 269

EP - 272

JO - Breast Journal

JF - Breast Journal

SN - 1075-122X

IS - 2

ER -

ID: 230247160